Stockscreener 앱 받기
91.85
1.87%
-1.75
시장 영업 전:
91.74
-0.11
-0.12%
전일 마감가:
$93.60
열려 있는:
$92.95
하루 거래량:
515.59K
Relative Volume:
1.03
시가총액:
$3.47B
수익:
-
순이익/손실:
$-91.00M
주가수익비율:
-25.03
EPS:
-3.67
순현금흐름:
$-74.38M
1주 성능:
-1.51%
1개월 성능:
+6.78%
6개월 성능:
+74.26%
1년 성능:
+42.91%
1일 변동 폭
$91.52
$94.50
1주일 범위
$89.86
$99.50
52주 변동 폭
$30.82
$99.50
Disc Medicine Inc Stock (IRON) Company Profile
명칭
Disc Medicine Inc
전화
(617) 674-9274
주소
321 ARSENAL STREET, SUITE 101, WATERTOWN
IRON을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
91.85 | 3.53B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-03 | 재개 | Stifel | Buy |
| 2025-07-21 | 개시 | Truist | Buy |
| 2025-07-03 | 재개 | Morgan Stanley | Overweight |
| 2025-06-11 | 재개 | Raymond James | Strong Buy |
| 2025-02-27 | 개시 | TD Cowen | Buy |
| 2024-11-05 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | 개시 | Jefferies | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-08-22 | 개시 | Wells Fargo | Overweight |
| 2024-04-01 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | 개시 | H.C. Wainwright | Buy |
| 2023-05-17 | 개시 | Raymond James | Outperform |
| 2023-04-28 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-04-21 | 개시 | Stifel | Buy |
| 2023-04-20 | 개시 | Morgan Stanley | Overweight |
| 2023-03-23 | 개시 | BMO Capital Markets | Outperform |
| 2023-02-28 | 개시 | SVB Securities | Outperform |
모두보기
Disc Medicine Inc 주식(IRON)의 최신 뉴스
Frazier Life Sciences Management L.P. Has $87.64 Million Holdings in Disc Medicine, Inc. $IRON - MarketBeat
This is why Disc Medicine, Inc. (IRON) is a buy on Wall Street - MSN
All You Need to Know About Disc Medicine, Inc. (IRON) Rating Upgrade to Buy - MSN
Eventide Asset Management LLC Buys 126,212 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine, Inc. $IRON Position Lowered by Bain Capital Life Sciences Investors LLC - MarketBeat
Has Disc Medicine’s 2025 Surge Already Gone Too Far After Pipeline Progress Fuels Rally? - Yahoo Finance
Leering Partners Lifts Disc Medicine, Inc. (IRON) Following EPP Drug NDA Application - MSN
Discipline and Rules-Based Execution in IRON Response - news.stocktradersdaily.com
Disc Medicine (IRON): Reassessing Valuation After Encouraging RALLY-MF Phase 2 Anemia Data - simplywall.st
H.C. Wainwright reiterates Buy rating on Disc Medicine stock By Investing.com - Investing.com Canada
This is Why Disc Medicine, Inc. (IRON) is a Buy on Wall Street - Finviz
Disc Medicine stock price target raised to $115 by Leerink on MF anemia data - Investing.com Canada
Disc Medicine (NASDAQ:IRON) Sets New 12-Month HighTime to Buy? - MarketBeat
Disc Medicine Inc stock hits 52-week high at 97.63 USD - Investing.com Canada
Disc Medicine Inc stock hits 52-week high at 97.63 USD By Investing.com - Investing.com South Africa
ASH: Disc Set for Busy 2026 After Promising Interim Anemia Drug Data - Citeline News & Insights
Disc Medicine stock price target raised to $117 by Raymond James on trial data - Investing.com UK
Disc Medicine Advances Bitopertin in FDA Pilot Program - TipRanks
Disc Medicine, Inc. Reviews ASH Meeting Data and Operational Plans - TradingView — Track All Markets
Disc Medicine (NASDAQ:IRON) Builds Momentum In Clinical Science - Kalkine Media
IRON Stock Boosted by Positive Phase 2 Trial Results of DISC-097 - GuruFocus
Transcript : Disc Medicine, Inc.Special Call - marketscreener.com
Bollard Group LLC Takes Position in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine reveals encouraging Phase 2 data at ASH event - Traders Union
Disc Medicine reports positive data from DISC-0974 anemia trial By Investing.com - Investing.com Canada
Disc Medicine reports positive data from DISC-0974 anemia trial - Investing.com
Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting - The Manila Times
Disc Medicine Presents Positive Initial Data from RALLY-MF - GlobeNewswire
IRONAI Stock Analysis - Meyka
Saturn V Capital Management LP Sells 122,062 Shares of Disc Medicine, Inc. $IRON - MarketBeat
How Disc Medicine Inc. stock trades before earningsMarket Performance Summary & Consistent Growth Stock Picks - Newser
Disc Medicine Earnings Notes - Trefis
Certain Stock Options of Disc Medicine, Inc. are subject to a Lock-Up Agreement Ending on 5-DEC-2025. - marketscreener.com
Certain Pre-Funded Warrants of Disc Medicine, Inc. are subject to a Lock-Up Agreement Ending on 5-DEC-2025. - marketscreener.com
Disc Medicine, Inc. $IRON Shares Acquired by Sio Capital Management LLC - MarketBeat
Is Disc Medicine Inc. stock positioned well for digital economy2025 Institutional Moves & Growth Focused Stock Pick Reports - Newser
Disc Medicine (IRON) Stock Analysis Report | Financials & Insights - Benzinga
JPMorgan Chase & Co. Grows Position in Disc Medicine, Inc. $IRON - MarketBeat
Analysis Recap: How Disc Medicine Inc stock trades before earnings2025 EndofYear Setup & Free Verified High Yield Trade Plans - BỘ NỘI VỤ
Disc Medicine announces public offering of common stock and pre-funded warrants - MSN
Geode Capital Management LLC Purchases 26,605 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Behavioral Patterns of IRON and Institutional Flows - news.stocktradersdaily.com
DNB Asset Management AS Takes $243,000 Position in Disc Medicine, Inc. $IRON - MarketBeat
Is Disc Medicine Inc. stock attractive for hedge fundsRecession Risk & Expert Curated Trade Ideas - BỘ NỘI VỤ
Portfolio Adjustment: Institutional Heavyweight Exits Biotech Stock - AOL.com
Ensign Peak Advisors Inc Purchases 69,032 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Disc Medicine stock hits 52-week high at 96.09 USD By Investing.com - Investing.com Nigeria
Disc Medicine stock hits 52-week high at 96.09 USD - Investing.com
FY2025 EPS Estimate for Disc Medicine Decreased by Analyst - MarketBeat
Disc Medicine Inc (IRON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):